although the sustained-release formulation of dl-threo-methylphenidate ( ritalin-sr ) has been demonstrated to be effective in sustaining the attention of the children with attention deficit-hyperactivity disorder , there are no data on plasma levels of methylphenidate after administration of the sustained-release formulation .
C1263846
attention deficit-hyperactivity disorder
C0025810
methylphenidate